"What we need now is wide-spread action," adds Carol Brown, MD, a gynecologic oncologist at Memorial Sloan-Kettering Cancer Center and SGO's Government Relations Committee Chair. "The bill has been introduced, but it hasn't been passed yet. We are so appreciative that the Ovarian Cancer Biomarker Research Act has come this far, and we are grateful for the help and support we have received from Congressmen Berman and Hall, but we need to make sure that that this bill is passed. We need every woman, every family, every physician to contact their Congressmen and express their support for the Ovarian Cancer Biomarkers Research Act. It is quite literally -- and quite unfortunately -- a matter of life and death."
Adds Lindy Graham, an ovarian cancer survivor and advocate, "We absolutely need to pass this bill so our daughters, sisters, mothers, friends and neighborhood of women will finally be able to obtain early ovarian cancer detection that will ultimately save lives. No more sneak attacks from this disease!"
The Society of Gynecologic Oncologists (SGO) is a national medical
specialty society for physicians trained in the comprehensive management of
women's cancers. The Society's membership is primarily comprised of
gynecologic oncologists -- obstetrician/gynecologists who undertake an
additional 3-4 years of intensive training in the specific study of
gynecologic cancers. SGO members provide medical and surgical care to women
with ovarian cancer, cervical cancer, endometrial cancer, vulvar cancer,
and vaginal cancer. They are trained to in chemotherapy and radiation
|SOURCE Society of Gynecologic Oncologists|
Copyright©2007 PR Newswire.
All rights reserved